In addition, the pro-inflammatory role of TLR9 in NASH has been further confirmed in atherogenic diet-fed NASH and foz mouse models, demonstrating reduced pro-inflammatory cytokine production and attenuated hepatic neutrophil infiltration in TLR9−/− mice [133]. The gene discussed is TLR9; the disease is metabolic dysfunction-associated steatohepatitis.